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The prolactin receptor (PRLR) is activated by binding
of prolactin in a 2:1 complex, but the activation
mechanism is poorly understood. PRLR has a
conserved WSXWS motif generic to cytokine class I
receptors.We have determined the nuclear magnetic
resonance solution structure of the membrane prox-
imal domain of the human PRLR and find that the
tryptophans of the motif adopt a T-stack confor-
mation in the unbound state. By contrast, in the
hormone bound state, a Trp/Arg-ladder is formed.
The conformational change is hormone-dependent
and influences the receptor-receptor dimerization
site 3. In the constitutively active, breast cancer-
related receptor mutant PRLRI146L, we observed
a stabilization of the dimeric state and a change in
the dynamics of the motif. Here we demonstrate
a structural link between theWSXWSmotif, hormone
binding, and receptor dimerization and propose
it as a general mechanism for class 1 receptor
activation.
INTRODUCTION
The prolactin receptor (PRLR) is a member of the cytokine
receptor superfamily. Cytokine receptors are divided into three
parts: (1) an extracellular N-terminal domain (ECD) forming two
fibronectin type III (FNIII) domains, an N-terminal, membrane-
distal domain termed D1 and a membrane-proximal domain,
D2; (2) a single transmembrane a-helical segment; and (3) the
C-terminal intracellular domain (ICD), which is structurally un-
characterized, containing binding sites for various protein part-
ners involved in intracellular signaling, including Janus kinase 2
(JAK2) (Goffin et al., 2002; Rui et al., 1994).
The primary roles of the PRL/PRLR complex involve stimula-
tion of lactation in the nursing female and the development of270 Structure 20, 270–282, February 8, 2012 ª2012 Elsevier Ltd All rbreast epithelium during pregnancy (Neville et al., 2002). In
males, it participates in the growth and differentiation of the
prostate (Goffin et al., 2011; Nevalainen et al., 1997; Robertson
et al., 2003). PRL/PRLR has been linked to stimulation of tumor
growth with elevated PRL and/or PRLR levels (Carver et al.,
2009; Clevenger et al., 2009). This has precipitated extensive
pharmaceutical work on the development of PRLR antagonists
(Goffin et al., 2005). Genetic analyses of patients presenting
with benign or malignant breast tumors have recently revealed
the existence of two PRLR alleles encoding missense receptor
variants, hPRLRI76V and hPRLRI146L (Bogorad et al., 2008; Can-
bay et al., 2004; Courtillot et al., 2010; Vaclavicek et al., 2006).
Functional analyses showed both variants to be active in the
absence of hormone, with hPRLRI146L the most potent. Its bio-
logical activity was considered relevant, as hPRLRI146L activated
both JAK2/STAT5 and MAPK-pathways; it activated a PRL
target reporter gene, promoted autonomous breast cancer cell
proliferation, and immortalized Ba/F3 immune cells (Bogorad
et al., 2008; Courtillot et al., 2010). The I146L variant was not
found in the control cohorts of the epidemiological studies, sug-
gesting its potential involvement in breast pathogenesis.
PRL is a four-helix bundle protein (Teilum et al., 2005) that
activates its cognate receptor by forming an asymmetric ternary
complex binding two identical receptor molecules (Broutin et al.,
2010; van Agthoven et al., 2010). Atomic models of 1:1 and 1:2
complexes of PRL (and derivatives thereof) and PRLR-ECD are
available (Broutin et al., 2010; Kulkarni et al., 2010; Svensson
et al., 2008; van Agthoven et al., 2010), which characterize
the details of the hormone/receptor interfaces, as well as of
the receptor-receptor interaction site 3, Figure 1A. The two
hormone-receptor interfaces are referred to as sites 1 and 2
with site 1 binding with nM affinity, and site 2 more weakly in
the mM range (Jomain et al., 2007). The PRL binding sites involve
both D1 and D2. The PRLR-D2 participates in hormone-binding,
mainly via Trp139, which is located in loop-L5 (Broutin et al.,
2010), here referred to as the binding-loop. The structure of the
2:1 complex has furthermore revealed that the two receptors
interact via contacts between the D2 domains. This interface is
referred to as site 3.ights reserved
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Figure 1. Structure and Spectroscopic Data on hPRLR-ECD
(A) Structure of the 2:1 complex between hPRL and the ECDs of two
rPRLRs (van Agthoven et al., 2010). The ECDs, shown in green, each
consists of two FNIII domains, D1 and D2. The hormone in blue primarily binds
to D1 with the bulk of the interface buried in site 1. The WS motif is shown
in red.
(B) The [15N,1H]-HSQC spectrum of hPRLR-D2 shows a large dispersion in the
proton dimension indicative of a folded, globular domain. Asn and Gln side
chains peaks are linked by solid lines. The spectrum was recorded on 0.5 mM
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Structure 20, 27Not much is known about the molecular details of receptor
activation, mainly because no structure of the receptor in the
unbound state is available. Elegant alanine-insertion studies
in the growth hormone receptor (GHR) have indicated that
hormone binding most likely forces a translation of one of the
transmembrane helices leading to a rotation of the ICDs and
activation of the JAK2 kinases (Brown et al., 2005). Similar exper-
iments recently ruled out a corresponding mechanism for PRLR
and hence the manner in which the signal is transduced remains
obscure (Liu and Brooks, 2011).
The D2 domain of PRLR contains an interesting structural
feature, namely a highly conserved Trp-Ser-Xaa-Trp-Ser motif
(Xaa is any amino acid), here referred to as the WS motif. This
motif—or conservative variations thereof—is observed in all
cytokine receptors. In the bound state of rat PRLR (rPRLR)
(Broutin et al., 2010), the two Trp side chains are stabilized by
strong p-cation stacking with Arg side chains, forming a struc-
tural motif that we have designated as the Trp/Arg ladder. The
WS motif, and indeed the entire Trp/Arg ladder, is positioned
opposite the PRL binding loop and the receptor dimerization
interface. However, mutations of the WS motif to all-alanine in
rPRLR decreased binding affinity for ovine PRL 23-fold
(Rozakis-Adcock and Kelly, 1992). An exhaustive mutation study
of 19 individual single amino acid substitutions of each of the five
residues of the WS motif in the erythropoietin receptor (EPOR)
revealed an extremely limited tolerance toward changes (Hilton
et al., 1996). Furthermore, roles for the WS motif in receptor
folding, membrane trafficking, and binding were suggested
(Yoshimura et al., 1992). The residues most sensitive to changes
were Trp232 and Trp235, corresponding to the human PRLR
(hPRLR) residues Trp191 and Trp194 (Hilton et al., 1996; Yoshi-
mura et al., 1992). By analogy, humans (and chickens) homozy-
gous for a GHR mutant with the second Ser of the WS motif
substituted for Leu suffer from Laron dwarfism syndrome (Duriez
et al., 1993; Jorge et al., 2004), a condition which cannot be
reversed by the administration of GH. Free-energy perturbation
calculations on the interleukin-4 receptor suggested a role for
the WS motif as a gatekeeper, ensuring a nonactive state via
interactions with the lipid membrane (Weidemann et al., 2007).
So far, however, a general role in receptor triggering is lacking.
We have characterized the extracellular domain of the hPRLR
and present, to our knowledge, the first structural description of
the hPRLR off-state. In atomic detail, the WS motif acts as a
molecular switch controlling whether the receptor is in the off-
state or in the on-state. Our results indicate an allosteric commu-
nication line from the hormone binding site via the WS motif and
extracellular dimerization site 3 to the membrane-proximal pole
of the receptor.
RESULTS
Initially, the solution structure of unbound hPRLR-ECD was
pursued. Even with per-deuterated protein, a significant lack of13C,15N hPRLR-D2 in 10% (v/v) D2O, 10 mM NaH2PO4, 10 mM TCEP,
1 mM DSS, and 0.02% (v/v) NaN3 (pH 7.4) at 25
C.
(C) Overlay of [15N,1H]-HSQC spectra of 15N hPRLR-D2 and [15N,1H]-TROSY-
HSQC of 2H, 15N hPRLR-ECD shown with black and red peaks, respectively.
See also Figure S1.
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Figure 2. NMR Solution Structure Ensemble of hPRLR-D2
(A) Stereo view (cross-eyed) of the 10 lowest energy structures aligned
using backbone atoms of the seven b strands, root mean square deviations of
0.4 ± 0.1 A˚.
(B) Schematic representation of the lowest energy structure of hPRLR-D2.
(C) Topology representation of hPRLR-D2. Arrows indicate the directions of
the b strands A–G. The N-terminal, C-terminal, binding loop, and WS motif are
labeled. The b strands are indicated by residue numbers.
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Off-State of the Human Prolactin Receptorsignals was evident in the [1H,15N]-transverse relaxation opti-
mized spectroscopy (TROSY)-heteronuclear single quantum
coherence (HSQC) spectrum. More critically, the triple-reso-
nance heteronuclear nuclearmagnetic resonance (NMR) spectra
were of poor quality, impairing sequential assignment of chemi-
cal shifts and suggested undesired conformational dynamics,
aggregation, or oligomerization of hPRLR-ECD under the condi-
tions of the NMR experiment. Hence, the two domains of
hPRLR-ECD were expressed individually.
The [1H,15N]-HSQC spectrum of hPRLR-D1 revealed this to be
responsible for the lack of signals in the spectra of hPRLR-ECD
(Figure S1 available online). hPRLR-D2 gave instead rise to a
[1H,15N]-HSQC spectrum with the expected number of signals
and a dispersion indicating a folded domain in the absence
of hPRLR-D1 (Figure 1B). When overlaid with the [1H,15N]-
TROSY-HSQC spectrum of 2H15N-hPRLR-ECD, most signals
were readily superimposable (Figure 1C), suggesting the struc-
ture of isolated hPRLR-D2 to closely resemble that in
hPRLR-ECD.
Structure of the Unbound hPRLR-D2 and Differences
Between Unbound and PRL-Bound Receptor
Assignments of resonances in hPRLR-D2 resulted in a com-
pleteness of 92.8% in all backbone and side chain resonances,
and the final structure set yielded the statistics shown in
Table S1A. A stereo image of the backbone ribbon of the
ensemble and a ribbon representation of the structure is shown
in Figures 2A and 2B. Seven b strands (A–G) are present forming
two antiparallel b sheets (Figure 2C). One sheet contains
three short strands (A, Leu107-Lys114; B, Tyr122-Ser128; E,
Glu166-Ile169) and the other consists of four strands with strand
F extended compared to the others (C, Tyr144-Pro150; D,
Glu157-Gly162; F, Lys177-Cys184; G, Thr198-Ile202). The struc-
ture of the unbound hPRLR-D2 represents an FNIII fold.
To our knowledge, the structure of hPRLR-D2 provides the
first insight into the unbound state of PRLR. Compared to
published structures of full-length PRLR-ECD with PRL bound,
our current hPRLR-D2 structure has an overall similar fold to
the D2 domain in bound hPRLR-ECD with Ca root mean square
deviations ranging from 1.2 A˚ to 1.7 A˚ (Table S1B). Striking local
differences were observed between the free and the PRL-bound
states, especially in the composition of the two sheets (Fig-
ure 3A). Compared to the bound state of the hPRLR-ECD, the
C and F strands were prominently shorter in hPRLR-D2, and
the A and B strands were slightly longer.
Pronounced conformational differences in the conserved WS
motif in which all PRLR-ECD complex structures have a struc-
tured Trp/Arg ladder were observed (Figure 3B). Such an
arrangement is only partly formed in unbound hPRLR-D2. The
lower part of the ladder consisting of Lys149-Trp156-Arg147-
Trp194 was formed, whereas the upper part of the ladder
involving the indole rings of Trp191 and Trp194 of the WS-motif
were observed in an edge-to-face arrangement (Figure 3C). The
proton resonances from the side chain of Arg183 involved in
stacking with the Trp side chains in the bound state were absent
in the total correlation spectroscopy (TOCSY) and nuclear
Overhauser enhancement spectroscopy (NOESY) spectra. By
contrast, the formation of the lower part of the Trp/Arg ladder
was supported by distinct NOEs.272 Structure 20, 270–282, February 8, 2012 ª2012 Elsevier Ltd All rights reserved
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Figure 3. Comparison of Free and Bound States of hPRLR-D2
(A) Overlay of hPRLR-D2 (gray) with the structure of D2 from hPRLR-ECD (green) extracted from the 1:1 bound state (Protein Data Bank ID:3D48). The two
structures were aligned by PyMOL; for clarity, residues prior to 107 are not shown in hPRLR-D2.
(B) Structure of bound hPRLR-D2 (Protein Data Bank ID:3D48). The Trp/Arg ladder residues Lys149, Trp156, Arg147, Trp194, Arg183, Trp191, and Lys185 are
shown in red.
(C) Structure of unbound hPRLR-D2 with hydrogen atoms omitted. The T-stack of Trp191 and Trp194 and the remaining side chains participating in Trp/Arg
ladder in the bound state are displayed in red.
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The existence of two different structural states of the receptor,
one adopting a Trp/Arg ladder conformation in the bound state
(Figure 3B) and the other an edge-to-face conformation in the
unbound state (Figure 3C), was supported by circular dichroism
(CD) analysis. An edge-to-face orientation of the indole rings of
Trp gives rise to a characteristic positive ellipticity from p-p*
exciton-coupling around 230 nm (Wu et al., 2009). Intense posi-
tive ellipticities at 230 nm for hPRLR-ECD and 228 nm for
hPRLR-D2 and a broad band at 210-213 nmwere observed (Fig-
ure 4A). The edge-to-face conformation is termed a T-stack. In
the structure of unbound hPRLR-D2, T-stacking was observed
for Trp191 and Trp194. Although the present NOE set was not
sufficient to orient the T-stack optimally (see below), no other
aromatic rings in hPRLR-D2 appeared to engage in such an
arrangement.
To support the conclusion of a T-stack in the unbound state of
hPRLR-D2, we selectively labeled the Cd of Phe and Tyr, Cd2 and
C 31 of His, and Cd1 and C 3 of Trp using 13C1-glucose (Teilum
et al., 2006) and recorded a [1H,13C]-TROSY-HSQC. Especially
for Trp side chains, the only protons that would be connected
to a 13C-labeled carbon using this selective labeling approach
would be H 3 protons. If a T-stack was present in hPRLR-D2,
this would give rise to a significantly up-field shifted H 3 of the
edge Trp (Andersen et al., 2006) in this case of Trp191. We
observed a peak at 5.1 ppm/132 ppm diagnostic of a T-stack
(Figure 4B). Recursively, from the NOESY spectra, this peak
was assigned to H 3 of Trp191, confirming the presence of the
T-stack between Trp191 and Trp194 (Figure 4C). The aromatic
rings of Trp191 and Trp194 in the final structure of hPRLR-D2
seem too far apart to what is suggested from the ring cur-
rent shifts, and it appears that the present set of NOEs is not
adequate in defining the orientation of the rings precisely.
Thus, dynamics as manifest in intermediate exchange in the
15N dimension, where the peak is broad, supporting a possible
exchange process (Figure 4B).Structure 20, 27Finally, we investigated whether the T-stack in hPRLR-ECD
also implicated Trp191 and Trp194. Although the NMR spectrum
also contained peaks from hPRLR-D1, the superimposition of
peaks from hPRLR-D2 made the transfer of assignments in the
Trp indole region of the HSQC spectrum straightforward. A
comparison of the NMR signals from the indole NH protons of
hPRLR-ECD and -D2 in their unbound states showed that the
chemical environment around these are likely similar, supporting
the presence of the T-stack in hPRLR-ECD (Figure 4D).
The T-Stack Rearranges to Form the Trp/Arg-Ladder
by PRL Binding
The structures of the PRL-bound state of PRLR-ECD suggested
that the T-stack of the unbound state rearranges to form the
Trp/Arg ladder in the bound state. The Trp exciton coupling
was used to follow hormone binding by comparing the far-UV
CD spectra of unbound and hPRL-bound hPRLR-ECD (Fig-
ure 4A). This was done by subtracting the CD spectrum of the
sum of the spectra of PRL and hPRLR-ECD from that of the
spectrum of the hPRL:hPRLR-ECD complex. A significant loss
in signal intensity was seen at 228 nm. A loss of the Trp-Trp
p-p* exciton coupling upon PRL binding would expectedly
lead to a concomitant loss of an opposite signed feature at
216 nm, which is not observed here. However, because forma-
tion of the complex between PRLR-ECD and PRL leads to
increased b-sheet and a-helix stabilization, this will mask the
signature at 216 nm. Thus, it appears that PRL binding to
PRLR-ECD leads to a conformational change involving the WS
motif as suggested from the structures.
Titration of 15N-labeled hPRLR-D2 with unlabeled hPRL
resulted in the chemical shift changes shown in Figure 5B.
Although small, these were reproducible, as similar results
from three individually prepared samples were obtained. The
chemical shift changes in hPRLR-D2 were spread throughout
the domain, with minimal changes in the b strands. The largest
chemical shift changes were observed in the binding loop0–282, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 273
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Figure 4. The WS Motif in hPRLR-D2 and ECD Adopts a T-Stack Conformation in the Unbound State
(A) Far-UV CD spectra of free hPRLR-D2 (dashed) and free hPRLR-ECD (solid) recorded on 5 mM protein samples in 10 mM Na2HPO4 (pH 7.4).
(B) Aromatic [13C,1H] TROSY-HSQC spectrum of 13C1-labeled hPRLR-D2. The peak at 134/5.1 ppm (red circle) stems from Trp191 H
3 and is indicative of an
edge-to-face Trp-Trp stacking.
(C) The NOEs involving indole resonances of Trp191 shown on the hPRLR-D2 structure. Trp191 is shown in red, with NOEs indicated by dashed lines and contact
residues labeled and shown as sticks.
(D) Overlay of the Trp indole region of hPRLR-D2 and hPRLR-ECD [15N,1H]-HSQC spectra in red and blue, respectively. The full spectra are shown in Figure 2B.
The additional blue peak at 129.5/9.55 ppm is from the hPRLR-D1.
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Off-State of the Human Prolactin Receptor(residues 132–133 and 138–141), the N terminus (residues 100–
102), the parallel loop adjacent to the conserved WS motif (resi-
dues 188–195) and the loop between b strands A and B (AB loop;
residues 117–120) (Figure 5C). The chemical shift changes
observed for the binding loop are in accordance with recently
published structures (Broutin et al., 2010; Svensson et al.,
2008; van Agthoven et al., 2010) and were corroborated by cor-
responding shifts in binding site 1 of 15N-hPRL when titrated with
hPRLR-D2 (Figure S2). The chemical shift changes in the
conserved WS motif of hPRLR-D2, which is located opposite
the binding interface, as well as in the AB loop most distant
from the binding loop, were more surprising. The AB loop
exhibited chemical shift changes of the same magnitude as
those of the binding loop. Thus, the binding of hPRL dis-
seminates from the binding pole of hPRLR-D2 to the membrane
proximal pole.
Nine additional residues positioned more than 5 A˚ from any
binding site residue were affected by hPRL binding. Five of
these—Ile146, Glu151, Glu155, Tyr178, and Arg183—are evolu-
tionarily conserved. The chemical shift changes observed for
Tyr178 and Lys185, both of the F strand, were presumably due
to the b-strand extensions observed in structures of hormone-
bound PRLR. Residues Glu151, Lys152, and Glu155 are all274 Structure 20, 270–282, February 8, 2012 ª2012 Elsevier Ltd All rlocated in the CD loop, and the changes observed for these
residues could be a direct effect of the changes observed for
Tyr178 through van der Waals interactions. Finally, Phe206 is
close to the AB loop.
A similar approach was taken to analyze PRL-induced
chemical shift changes in hPRLR-ECD. This was hampered
by large shifts and the aforementioned difficulty of obtaining
triple-resonance spectra for assignment. As an alternative, we
focused on the region of the indole NH resonances of hPRLR-
ECD (Figure 5D). Here, the assignments from D2 were readily
transferable, and only two peaks were observed to change in
response to PRL binding. These were Trp139 from the binding
loop and Trp191 rearranging the T-stack to the Trp/Arg ladder.
Impact on Site 3 Residues by the Constitutively Active
hPRLRI146L Mutation
The constitutively active receptor-variant hPRLRI146L was
anticipated, at least in part, to be able to assume the active
conformation of the receptor in the absence of ligand. Because
of the partial constitutive activity observed for the I146L-variant,
it might provide information relating to the bound state of the
hPRLR as well as to the activation process. This prompted
a comparative study of hPRLRI146L versus wild-type.ights reserved
A B
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Figure 5. Titration Experiments of hPRL with hPRLR-D2 and ECD
(A) Far-UVCD spectra of the 1:1 hPRLR-ECD:hPRL complex (solid line), sum of the spectra of hPRLR and hPRLR-ECD (dashed line), and the difference spectrum
of complex and sum highlighting the structural changes by complex formation (dashed/dotted line).
(B) Chemical shift perturbations of hPRLR-D2 titrated with hPRL. The weighted average and average plus 1 SD are marked by a horizontal black and red line.
Secondary structures are indicated by gray bars, and the WS motif is indicated by a red bar.
(C) hPRLR-D2 residues with Dd above 1 SD from the average are shown in red on hPRLR-D2.
(D) Spectra of 2H, 15N-hPRLR-ECD with (red) and without (blue) hPRL present in a 1:2 molar ratio. The Trp indole region of the [15N,1H]-TROSY-HSQC spectra is
shown, with Trp139 of the binding loop and Trp191 of the WS motif experiencing the largest changes (arrows).
See also Figure S2.
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Off-State of the Human Prolactin ReceptorAttempts to obtain hPRLR-ECDI146L by refolding were unsuc-
cessful. The same mutation was therefore introduced into
hPRLR-D2, producing a folded hPRLR-D2I146L. Importantly,
the positive ellipticity at 228 nm seen in unbound hPRLR-D2
and hPRLR-ECD (Figure S3) was retained, suggesting a comple-
mentary origin for the associated constitutive activity. We
compared the backbone N-HN chemical shifts of hPRLR-D2
and hPRLR-D2I146L (Figure 6A). The largest chemical shift
changes were observed for residues within a distance of 5 A˚
from the mutation site and were attributed to local chemical
changes introduced by the mutation. Two groups of residues
further than 5 A˚ from the mutation site also showed significant
chemical shift changes. The first group of Gly162-Gln164,
Lys168, Ser171 and His173 (Figure 6B) are all located in the
site 3/receptor-dimerization interface. The second group of
Ala110, Val111, and Glu112 in the A strand and Tyr122,
Leu123, and Ser128 in the B strand are located in the strands
restructuring upon dimerization. Finally, changes were observed
for Thr198 and Phe199, which interact closely with the affected A
strand Val111.Structure 20, 27Altered Dimerization Potential of hPRLR-D2I146L
as the Origin of Constitutive Activity
Global and local dynamic properties of hPRLR-D2 and hPRLR-
D2I146L were assessed from NMR relaxation measurements of
backbone 15N spins (Figure 7). The ratio between the transversal
relaxation rate, R2, and the longitudinal relaxation rate, R1, for
residues in structured parts of the polypeptide chain represents
an estimate of the overall rotational correlation time, tC, of the
protein. Residues in flexible regions such as loops with internal
dynamics faster than tC will have R1 values higher than average
and R2 values lower than average, and vice versa for dynamics
slower than tC.
For the wild-type, the relaxation data are typical for a stable
protein of around 100 residues. The relaxation rates are fairly
similar for the residues in the b strands, which are assumed
to be the most rigid parts of the protein. The binding loop
(Asp134-Leu143), the parallel loop (Asp187-Gly189), and the
C- and N-terminal regions have R1 values significantly above
and R2 values significantly below the averages, indicating dyn-
amics faster than the overall rotational diffusion of the molecule.0–282, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 275
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Figure 6. Comparison of the Chemical Shift of hPRLR-D2 and hPRLR-D2I146L
(A) Backbone amide chemical shift differences (Dd = ((DdH)
2 + (0.25*DdN)
2)0.5) between free hPRLR-D2 and the free hPRLR-D2I146L (spaces represent proline
residues). Theweighted average ismarked by a horizontal red line. Positions of the b strands are indicated by gray bars, and theWSmotif is indicated as a red bar.
Asterisks indicate residues with significant chemical shift changes that are located more than 5 A˚ from the mutation site. Green bars indicate residues with site 3
interactions in the bound state.
(B) Residues with Dd above average and positioned more than 5 A˚ from the mutation site. In green residues of site 3 and in black residues outside site 3, Ile146 is
shown as cyan sticks. The structure is rotated to illustrate both sides of the b sandwich.
See also Figure S3.
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Off-State of the Human Prolactin ReceptorFrom the relaxation data, tC was estimated to 9.9 ns for hPRLR-
D2 by the program Tensor2 (Dosset et al., 2000). For a few resi-
dues, and most distinctly for Glu108, Arg183, and Trp194, R2 is
slightly elevated, which may be an indication of conformational
exchange on the milli- to microsecond time scale (Figure 7A).
The relaxation data from the hPRLR-D2I146L mutant showed
two distinct differences as compared to the wild-type data. First,
there is a general increase in R2. Consequently, the average
R2, hR2i = 21.7 ± 0.8 s1 and hR2/R1i = 19.2 ± 1.5 are signifi-
cantly higher than for wild-type where hR2i = 15.7 ± 0.7 s1
and hR2/R1i = 13.8 ± 1.2. This difference suggests an increase
in tC, which is estimated to 11.7 ns for hPRLR-D2
I146L. This
may be explained by transient dimerization. If we, as a first
approximation, assume spherical geometry of both the mono-
mer and the dimer, full dimerization will result in doubling of tC.
The increase in tC, from 9.9 ns to 11.7 ns, thus corresponds to
hPRLR-D2I146L being 18% dimeric. Second, for more residues
than seen in the wild-type, R2 is increased above the average
and the increase is larger. Specifically, the increase is most
pronounced for residues in the N terminus and for residues in
the WSmotif (Figures 7A and 7D). Taken together, the relaxation
data suggest that hPRLR-D2I146L undergoes fast, transient
dimerization and slow conformational exchange in the WSmotif.
To explore the possibility of a dimeric state of hPRLR-D2I146L,
the hydrodynamic radius was determined by NMR diffusion
experiments, as well as by small-angle X-ray scattering (SAXS)
analysis (Table 1). Here, it was evident that the two proteins
exhibited similar hydrodynamic radii, RH, of around 22 A˚ in
solution. The measured radii are in close agreement with the
theoretical hydrodynamic radius of 23 A˚ calculated with
HYDROPRO for a monomer using the hPRLR-D2 solution struc-
ture. Thus, hPRLR-D2 and hPRLR-D2I146L both exist predomi-
nantly as monomers in solution. However, the resolution of the
two methods does not allow the detection of a low populated
dimer state (<20%), which could discriminate the two receptor
variants.276 Structure 20, 270–282, February 8, 2012 ª2012 Elsevier Ltd All rTo rule out the possibility that the differences in relaxation
rates between hPRLR-D2 and hPRLR-D2I146L could be due to
a global destabilization and unfolding, their global stability,
DGH2ON-D, against chemical denaturation were determined by
intrinsic fluorescence (Figure 8). The I146L mutation caused no
significant destabilization of hPRLR-D2 within one standard
deviation with DGH2ON-D of 41 ± 3 kJ mol1 (hPRLR-D2)
and 38 ± 5 kJ mol1 (hPRLR-D2I146L).
DISCUSSION
To our knowledge, our structural characterization of the PRLR
provides for the first time insight into the role of the conserved
WSmotif in cytokine receptor activation. The hPRLR-D2 solution
structure revealed structural differences by comparison to
structures of the D2 domain of hormone-bound receptors
(1F6F, 3EW3, 3D48, 3MZG, and 3NPZ) and other members of
this cytokine receptor family, such as EPOR (1EER) and GHR
(2AEW). The differences consistently mapped to the WS motif
and to the lengths of the b strands constituting the two sheets
characteristic of the FNIII domain. In the unbound hPRLR-D2,
an edge-to-face orientation forming a T-stack of Trp191 and
Trp194 from the WS motif was observed via a highly upfield
shifted H 3 resonance of Trp191 and supported by a character-
istic aromatic exciton coupling measured by far-UV CD spec-
troscopy. The T-stack also exists in the full hPRLR-ECD, which
indicates a specific role for this structure.
The description of the T-stack orientation of the WS motif in
PRLR is unprecedented in any cytokine receptor. Crystal struc-
tures of the EPOR and the GHR have been published in the free
(1ERN and 2AEW) and bound states (1EER and 1A22). These
reveal that the cytokine binding sites of two adjacent molecules
of the free form interact to form a large crystal-packing interface
(1700 A˚2), matched by a similar 960 A˚2 crystal-packing interac-
tion in GHR. In all states of EPOR and GHR, theWSmotif adopts
the ladder conformation. However, CD spectra of their free formsights reserved
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Figure 7. Relaxation Properties of hPRLR-D2 and hPRLR-D2I146L
(A and D) Transverse relaxation rate constants, R2. The trimmed averages are: hPRLR-D2, < R2 > = 15.7 ± 0.7 s
1 and hPRLR-D2I146L, < R2 > = 21.7 ± 0.8 s
1.
(B and E) Longitudinal relaxation rate constants, R1. The trimmed averages are: hPRLR-D2, < R1 > = 1.08 ± 0.07 s
1 and hPRLR-D2I146L, < R1 > = 1.1 ± 0.07 s
1.
(C and F) R2/R1 ratios. The trimmed averages are < R2/R1 > = 13.8 ± 1.2 for hPRLR-D2 and < R2/R1 > = 19.2 ± 1.5 for hPRLR-D2
I146L. All parameters are shown as
a function of the residue number, and the trimmed averages are marked by horizontal lines. Positions of the b strands are indicated by gray bars and theWSmotif
is indicated by a red bar. Missing data points are due to overlap and/or proline residues. Error bars represent the SE from fits of the experimental data.
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adopt the T-stack conformation in solution. Despite sequence
differences between the WS motif of hGHR (Bass et al., 1991)
and hPRLR, a positive edge-to-face 228 nm band is present
but less pronounced for hGHR. The CD spectra of unbound
EPOR (Narhi et al., 1997) and of unbound hPRLR are strikingly
similar. Both receptors have the characteristic positive aromatic
exciton coupling at 228 nm and the broad negative band at
210–213 nm, arguing for an aromatic contribution to the far-UV
CD and the presence of a T-stack in both structures. The first
Trp in the WS motif is the one that in the free state stacks
edge-on with the second Trp. The latter has the same orientation
in both states. In the two crystal structures of the free receptors,
the first residue (Trp209 in EPOR, Tyr222 in GHR) has higher B
factors than the second one (Trp212 in EPOR, Phe225 in
GHR). In the complex structures, the B factors are the same.Structure 20, 27Wepropose this reflects the fact that although the Trp/Arg ladder
is formed in the crystal without the cytokine, it does not reach the
local energy minimum of the cytokine-induced on-state.
There are presently five other solution structures of unbound
cytokine receptors with a WS motif available; the human inter-
leukin-6 receptor (IL6R) (Hecht et al., 2006), the cytokine-
binding-domain of the common b chain of the receptor for gran-
ulocyte macrophage colony-stimulating factor (D4bc) (Mulhern
et al., 2000), the granulocyte colony stimulating factor receptor
(Yamasaki et al., 1997), the signal transducer gp130 (Kernebeck
et al., 1999), and the C-terminal domain of the ciliary neurotro-
phic factor receptor (CNTFR) (Man et al., 2003). In all but D4bc
and CNTFR, there are missing assignments for Trp/Arg ladder
residues. Nonetheless, the Trp/Arg ladder is present in those
structures, suggesting that the formation is dictated by force
fields and not by experimental observation. However, when0–282, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 277
Table 1. Measured and Theoretically Estimated Hydrodynamic
Radii of hPRLR-D2 and hPRLR-D2I146L
Hydrodynamic Radius (RH) hPRLR-D2 hPRLR-D2
I146L
PSG-LED (A˚) 22.32 20.49
SAXS (A˚) RH (Rg) 25.5 (19.7 ± 0.03) 22.8 (17.6 ± 0.2)
HYDRO-PRO (A˚) 23 23
Hydrodynamic radius was calculated from the Protein Data Bank file as
described (Garcı´a De La Torre et al., 2000).
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Figure 8. Chemical Denaturation of hPRLR-D2 and hPRLR-D2I146L
Followed by Intrinsic Fluorescence
The normalized two-state GuHCl denaturation curves of the hPRLR-D2 (,)
and hPRLR-D2I146L (C) measured from emission at 342 nm at 25C with
excitation at 280 nm; the solid line indicates fits to two-state unfolding. Sample
conditions were 50 mM Na2HPO4, 10 mM TCEP (pH 7.4), and 5 mM protein.
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the T-stack is either partly formed as in IL6R, or when a shifted
Trp H 3 resonance has also been assigned, a stabilized T-stack
is observed as in CNTFR. Moreover, in the CD spectrum of
IL6R, the aromatic exciton coupling is present (Ozbek et al.,
1998), supporting T-stack conformation. Thus, the T-stack may
be a general trait of unbound cytokine receptors harboring the
WS motif.
The WS Motif Acts as a Hormone-Dependent Molecular
Switch
The reorganization of the WS motif leading to formation of the
Trp/Arg-ladder upon receptor activation could be hypothesized
to be allosterically controlled and initialized by hormone
binding. Key residues in PRL binding are Trp139 of the binding
loop and His188 of the parallel loop. The latter is directly con-
nected to the WS motif. Although modest, PRL binding led to
reproducible and significant changes in chemical shifts of resi-
dues in the binding loop, the parallel loop, the AB loop, and the
N-terminal and of residues involved in the Trp/Arg ladder
(Arg183 and Trp194). PRL induced restructuring of the T-stack
by CD for hPRLR-ECD, but not for hPRLR-D2. Moreover, titra-
tion of hPRLR-ECD with PRL pinpointed Trp191 with the largest
observed chemical shift change, even though it has no contact
with PRL. This underlines that hormone binding to hPRLR
induces a conformational switch in the WS motif and suggests
that conformational change plays a role in receptor activa-
tion. The generality of the conformational change from the
T-stack to the Trp/Arg ladder is supported by similar reported
loss of the aromatic exciton upon EPO binding to the EPOR-
ECD (Narhi et al., 1997), analogous to what we observed for
the hPRLR-ECD. Together with the presence of a Trp/Arg
ladder in all bound states of cytokine receptors, this suggests
a commonly observed on-state conformation by the Trp/Arg
ladder.
The structural differences between unbound and hormone-
bound hPRLR-D2 pinpointed here, combined with our additional
NMR data and spectroscopic data from other cytokine recep-
tors, imply a significant role for the two tryptophans of the WS
motif in keeping the unbound receptor in an inactive state.
T-stacks have been shown to stabilize hairpins by 5 kJ mol1
(Andersen et al., 2006). Thus, such a conformation in hPRLR
most likely provides a significant energetic contribution to
hPRLR off-state stabilization. Several mutations of residues in
WS motifs have been performed, showing effects on folding,
binding, and expression levels (Baumgartner et al., 1994; Hilton
et al., 1996; Rozakis-Adcock and Kelly, 1992). Mutation intro-
duced outside the motif however, could in principle stabilize or
destabilize either conformation, leading to either enhanced or278 Structure 20, 270–282, February 8, 2012 ª2012 Elsevier Ltd All rdecreased affinity for the hormone. This conundrum is so far
unresolved.
Additional support for a role of D2 in restraining the free
receptor in the off-state comes from deletion mutations per-
formed in rabbit (Gourdou et al., 1996) and in human (Tan
et al., 2008) PRLR. Cell-expressed D2-deleted receptors ex-
hibited ligand-independent activation of transcription in vitro,
suggesting a negative regulatory effect of D2 in hPRLR. A similar
deletion of D1 did not lead to constitutive activation but lowered
hormone affinity by three orders of magnitude and shifted the
activation profile to higher hormone concentration (Gourdou
et al., 1996; Kline et al., 2002). It was suggested that D2 is
responsible for a specific negative effect on signal transduction.
This negative effect, we suggest, is encoded in the WS motif
established in D2 to stabilize the off-state acting as a molecular
switch turned on by hormone binding.
Transient Dimers in the Constitutive Active Receptor
Variant
The analyses of relaxation and chemical shift changes between
hPRLR-D2I146L and wild-type (wt)-hPRLR-D2 mapped distinctly
to the site 3 residues as well as to the WS motif. The I146L
point mutation furthermore led to a redistribution of the
dynamics of the fibronectin core (Figure 7), leading to transient
dimerization detected by a decreased tumbling rate of the
mutant protein. Taken together with the constitutive activity
measured for full-length hPRLRI146L in cells, this finding
suggests that a low-lying excited state representing the on-
state of the receptor in the absence of the hormone is sampled
more often than in wt-hPRLR. That the T-stack, which stabilizes
the off-state, is still formed in hPRLR-D2I146L implies that
hPRLRI146L should not be fully active. This agrees with the
submaximal activity measured for the non-PRL-stimulated
hPRLRI146L variant. Thus, only when the Trp/Arg ladder and
D2-D2 interface are formed will the receptor be fully active. In
further support of this suggestion, it was found that the affinity
for the hormone in stably transfected HEK293 clones was iden-
tical for both receptors, but the efficacy was higher for the
constitutively active variant (Bogorad et al., 2008; Courtillot
et al., 2010).ights reserved
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Interface
The present study has provided insight into the off-state of the
PRLR receptor and into the path from the off-state to the acti-
vated on-state. Activation of PRLR involves allosteric modulation
of the WSmotif, which contributes to the stability of the off-state
by an edge-to-face T-stack of the Trp191 and Trp194 indole
rings. When the hormone interacts with the binding and parallel
loops, a conformational response is transmitted to create the
Trp/Arg ladder, mature the dimerization interface, and perturb
the AB loop. The results support the hypothesis that binding of
the first receptor is mandatory for forming a trimeric signaling
complex (Broutin et al., 2010), making sequential receptor bind-
ing compulsory. Although the receptors may be predimerized on
the cell surface (Gadd and Clevenger, 2006; Tallet et al., 2011),
they must be organized such that molecular switches will assure
the stability of the off-state. One such switch, the T-stack, has
been described here. The present elucidation of an allosteric
communication line from the hormone binding site via the WS
motif and the receptor site 3 to the membrane-anchored pole
of the receptor may represent themechanism by which hormone
binding is transmitted to the membrane. By analogy, the switch
mechanism and signal transduction network may be general
features of membrane-bound cytokine receptors. A detailed
understanding of these mechanisms will open novel routes to
the continued optimization of receptor antagonists.
EXPERIMENTAL PROCEDURES
Plasmids for Expression of the D1 and D2 Domains (NM_000949)
Recombinant hPRLR-D299–210 and hPRLR-D11–102 were amplified from
IRAKp961G13133Q (RZPD German Resource Center for Genome Research)
(primers in supplemental data), purified using the Wizards-plus-SV miniPrep
DNA (Promega, Madison, WI), and sequences were confirmed (MWG biotech,
Ebersberg, Germany).
Protein Expression and Purification
The hPRLR-D2 expression from E. coli BL21(DE3), either labeled or unlabeled
(Teilum et al., 2005), was induced with IPTG (1 mM) at OD600z0.6 for 4 hr at
37C, and cells were sonicated to bring hPRLR-D2 in solution. After
(NH4)2SO4 precipitation, 75% (w/v), stirring for 2 hr at 0
C, the precipitate
was dissolved in 30 mM NH4HCO3, 100 mM NaCl, and 1 mM dithiothreitol
(DTT) (pH 8.0) and applied to a SephadexG50-Fine (GE Healthcare) column
(24 3 370 mm, 167 ml). hPRLR-D2 fractions were pooled, concentrated,
and buffer exchanged. For structure determination, the NMR sample con-
tained 0.5 mM 13C,15N-hPRLR-D2 in 10% (v/v) D2O (or 99.9% D2O), 10 mM
NaH2PO4, 10 mM TCEP, 1 mM DSS, and 0.02% (v/v) NaN3 (pH 7.4). For the
relaxation experiment, a MonoQ column (1 ml, GE Healthcare) was introduced
to remove minor impurities, equilibrated in 20 mM Tris-HCl and 1 mM DTT
(pH 9), and eluted by a linear gradient of NaCl. The hPRLR-D2I146L followed
the same protocol. hPRL and hPRLR-ECD were purified as described (Teilum
et al., 2005); D1 followed the protocol for hPRLR-ECD. D1, hPRLR-ECD, and
hPRLR-D2I146L were either 2H,15N-labeled from M9 media grown in 99% D2O,
15N-labeled, or unlabeled from LB.
NMR Spectroscopy
Either an 800 MHz Varian INOVA spectrometer equipped with a 5 mm
triple-resonance cryoprobe with a Z-field gradient, or an 800 MHz Bruker
Avance spectrometer equipped with a 5 mm TCI cryoprobe was used to
record the following NMR experiments at 25C: [15N,1H]-HSQC, HNCO,
HN(CA)CO, HN(CO)CA, HNCA, CBCA(CO)NH, HNCACB, C(CO)NH, H(CCO)
NH, TOCSY 15N-HSQC, HCCH-TOCSY, NOESY 15N-HSQC (mix 150 ms),
aromatic NOESY-13C-HSQC (mixing time 100 ms), and aliphatic
NOESY-13C-HSQC (mix 140 ms). Assignment of aromatic side chains wasStructure 20, 27aided by HBCBCHCDHD and HBCBCGCDCEHE spectra (Yamazaki et al.,
1993). FIDs were processed using nmrPipe (Delaglio et al., 1995) and analyzed
using CcpNMR-Analysis (Vranken et al., 2005). Proton chemical shifts were
referenced directly to internal DSS at 0.00 ppm, with heteronuclei referenced
indirectly by relative gyromagnetic ratios.
Assignments and Structure Calculation
Assignments were performed in a combined automatic and manual process
aided by Autoassign (Zimmerman et al., 1997). NOESY peaks were manually
picked in CcpNMR. Torsion angle restraints were from TALOS (Cornilescu
et al., 1999). The three-dimensional structures were calculated by a com-
bination of automated NOESY peak assignment and torsion angle dynamics
implemented in CYANA (Gu¨ntert, 2003), as well as manual inspection and
assignments. The standard CYANA procedure of seven cycles of NOE
assignment and structure calculation was performed. Initially, 100 randomized
conformers were generated and subjected to 10,000 torsion angle dynamic
steps, and selecting 20 structures with the lowest target function value
between runs. Iteratively, assignments were checked manually, modified if
needed, and structures were recalculated. The final 250 structures were
calculated using Xplor-NIH (Schwieters et al., 2003) on the basis of the
lowest-energy structure from CYANA with the assigned NOEs and TALOS
dihedral angles as restraints. The secondary structure content was analyzed
using DSSP. A set of 10 lowest energy/no-violation structures were chosen
to represent the final structure and were refined in explicit water using
ARIA2 (Rieping et al., 2007).
15N Relaxation
The 15N spin relaxation experiments included determination of the longitudinal
(R1) and transverse (R2) relaxation rate constants and were recorded using
a standard HSQC sequence (Farrow et al., 1994) at a 750 MHz proton
frequency field. The relaxation decays were measured using seven (0, 0.2,
0.4, 0.6, 0.6, 0.8, 1.0, and 1.2 s) and six (0.01, 0.03, 0.05, 0.07, 0.09, and
0.11 s) different relaxation delays for R1 and R2. The number of transients
was 256 for hPRLR-D2 and 128 for hPRLR-D2I146L experiments. The sweep
width in the indirect dimension was minimized to allow for only 32 increments
with a recovery delay of 1.5 s. The relaxation decays were fitted to single
exponentials, and relaxation rates were determined. The samples were
0.5 mM and and 0.45 mM for 15N-hPRLR-D2 and 15N-hPRLR-D2I146L, with
buffers described as above. The overall correlation time for the rotational
diffusion, tC, was estimated from the R1 and R2 values of residues in the
b sheets using Tensor2 (Dosset et al., 2000).
Diffusion Measurements
Hydrodynamic radii were measured using PGSLED (Yao et al., 2000). The
gradient strength was changed linearly from 500 to 30,000 G/cm in 25 steps
with extra data points in the beginning. The signal intensity versus gradient
strength was measured on the aromatic and the methyl groups separately
and fitted to Gaussian decays. The hydrodynamic radius was calculated using
the following equation from Wilkins et al. (1999):
Rh=
daRha
dD2
;
with a-cyclodextrin as an internal reference, where da is the diffusion con-
stant of a-cyclodextrin and dD2 that of hPRLR-D2 (or hPRLR-D2
I146L). Rha is
the hydrodynamic radius of a-cyclodextrin (7.1 A˚). All experiments were
performed at 500 mM and 450 mM for hPRLR-D2 and hPRLR-D2I146L
in 10 mM Na2HPO4 (pH 7.4), 10 mM TCEP in 99.96% (v/v) D2O, and 1 mM
a-cyclodextrin at 25C.
SAXS
SAXS-data on hPRLR-D2I146L were recorded at the MAX-Lab synchrotron in
Lund, Sweden, at beam line I711. Data were recorded at 20C, exposure
time 180 s, wavelength 1 A˚. Scattering from three different concentrations
(1.1, 2.2, and 4.3 mg/ml) was collected in succession, each flanked by back-
ground (10 mM Na2HPO4, 10 mM TCEP [pH 7.4]) scattering measurements.
Data from the lowest concentration hPRLR-D2I146L sample were discarded
due to low signal-to-noise ratio. The others were merged and used for
further analysis. Data were processed using the ATSAS package (Konarev0–282, February 8, 2012 ª2012 Elsevier Ltd All rights reserved 279
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Off-State of the Human Prolactin Receptoret al., 2006). The hPRLR-D2 SAXS data were recorded at the HESYLAB
synchrotron in Hamburg, Germany, at beam line X33 at three different concen-
trations (0.92, 1.9, and 3.85 mg/ml) in 10 mM Na2HPO4 and 10 mM TCEP
(pH 7.4) at an exposure time of 30 s. Details are provided in the Supplemental
Experimental Procedures.
Binding Analysis
Two [15N,1H]-HSQC spectra were recorded and compared, one of a 55 mM 15N
hPRLR-D2, and one of a 55 mM 15N hPRLR-D2 and 435 mM unlabeled hPRL.
This was repeated three times. In the reverse experiment, two HSQC spectra
were recorded and compared; one of a 67 mM13C15N-hPRL sample and one of
a 67 mM 13C15N-hPRL and 135 mM unlabeled hPRLR-D2, all in 10% (v/v) D2O,
10 mM NaH2PO4, and 0.02% (v/v) NaN3 (pH 7.5).
CD Spectroscopy
Far-UV CD spectra were acquired from 200 nm to 250 nm at 20 nm/min,
bandwidth 1 nm and 2 s response time at 25C using a Jasco J-810 spectro-
polarimeter, 1 mm light path. 10 scans were averaged and buffers subtracted.
Protein concentration was 5 mM in a 10 mM Na2HPO4 (pH 7.4).
Fluorescence Spectroscopy
Chemical denaturation by GuHCl was followed using a Perkin Elmer LS50B
luminescence spectropolarimeter in a 5 mm quartz cuvette at room tempera-
ture. Titration series in the 0–6 M GuHCl range and 50 mM Na2HPO4, 10 mM
TCEP (pH 7.4), and 5 mMprotein with excitation at 280 nmwith 5 nm slit widths
were done. Emission was acquired from 300-400 nm, 100 nm/min, five scans
averaged. The change in emission intensity at 342 nm with GuHCl concentra-
tion was fitted to a two-state model (Maxwell et al., 2005).ACCESSION NUMBERS
The coordinates for the NMR solution structure of hPRLR-D2 have been
deposited in the Protein Data Bank (http://www.rcsb.org) under the accession
code 2LFG. Chemical shift assignments for hPRLR-D2 at pH 7.4 have been
deposited in Biological Magnetic Resonance Bank (http://www.bmrb.wisc.
edu/) under the accession number 17752.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
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